Celldex (NASDAQ: CLDX) reported Q1 EPS of ($1.18), $0.01 better than the analyst estimate of ($1.19). Revenue for the quarter came in at $15 thousand versus the consensus estimate of $874.9 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.